关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 2 3 2 2 1 9 9 位浏览者
您当前的位置:首页 >> 正文

高效液相色谱法同时测定蒙药复方述达格-4中6个成分的含量

Simultaneous determination of six components in Mongolian medicine compound formula Shudage-4 by HPLC

作者(英文):
分类号:R917
出版年·卷·期(页码):2018,38 (10):1817-1823
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立采用HPLC同时测定蒙药复方述达格-4中1-苯基-7-(3-甲氧基-4-羟基)苯基-5-醇-3-庚酮、高良姜素、山柰素、高良姜素-3-甲醚、α-细辛醚、木香烃内酯含量的方法。方法:采用C18色谱柱(4.6 mm×250 mm,5 μm),以乙腈-0.2%乙酸水溶液为流动相,梯度洗脱,流速0.6 mL·min-1,检测波长254 nm,柱温30℃,进样量为10 μL。结果:1-苯基-7-(3-甲氧基-4-羟基)苯基-5-醇-3-庚酮、高良姜素、山柰素、高良姜素-3-甲醚、α-细辛醚、木香烃内酯的进样量与其峰面积具有良好的线性关系(r=0.999 9);平均加样回收率(n=6)为96.6%~101.1%,RSD为0.70%~1.8%;测定样品6批,1-苯基-7-(3-甲氧基-4-羟基)苯基-5-醇-3-庚酮、高良姜素、山柰素、高良姜素-3-甲醚、α-细辛醚、木香烃内酯的平均含量分别为0.008 4%~0.060 0%、0.010 7%~0.061 6%、0.010 9%~0.086 5%、0.006 2%~0.066 6%、0.011 0%~0.078 1%、0.005 1%~0.060 6%。结论:该方法可用于蒙药复方述达格-4的质量控制,可为蒙药复方述达格-4资源开发利用提供理论依据。

-----英文摘要:---------------------------------------------------------------------------------------

Objective:To establish a method for simultaneous determination of 6 components including 1-phenyl-7-(3-methoxy-4-hydroxy) phenyl-5-ol-3-heptanone, galangin, kaempferide, galangin-3-methylether, alpha-asarone and costunolide in Mongolian medicine compound formula Shudage-4 by HPLC. Methods:Separation was performed on a C18 column(4.6 mm×250 mm, 5 μm) and the mobile phase consisted of acetonitrile-0.2% glacial acetic acid with gradient elution at a flow rate of 0.6 mL·min-1. The detection wavelength was 254 nm and the column temperature was 30℃. The injection volume was 10 μL. Results:1-phenyl-7-(3-methoxy-4-hydroxy) phenyl-5-ol-3-heptanone, galangin, kaempferide, galangin-3-methylether, alpha-asarone and costunolide exhibited good linear relationship with correlation coefficients of 0.999 9, the recoveries were 96.6%-101.1%, and the RSD were 0.70%-1.8%. The content ranges of the above mentioned components in 6 samples were 0.008 4%-0.060 0%, 0.010 7%-0.061 6%, 0.010 9%-0.086 5%, 0.006 2%-0.066 6%, 0.011 0%-0.078 1% and 0.005 1%-0.060 6%, respectively. Conclusion:The method can be applied in quality control of Mongolian medicine compound formula Shudage-4. The study can provide theoretical basis for development and utilization of Mongolian medicine Shudage-4.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 490位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn